Summit Therapeutics Inc. (SMMT) Executive Compensation
Summit Therapeutics Inc. (SMMT) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SMMT
CIK: 1599298
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 1/31/2017 12:00:00 AM
Lead Engagement PartnerDeepak Bhandarkar
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-08 | FORM 4 | 0001890784-26-000006 | View SEC Doc Filr Page |
| PRE 14A | 2026-10-06 | 2026-10-06 | PRE 14A | 0001193125-26-415755 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | 8-K | 0001193125-26-405776 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001599298-26-000081 | View SEC Doc Filr Page |
| 8-K | 2026-09-14 | 2026-09-13 | 8-K | 0001599298-26-000078 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-02 | 8-K | 0001599298-26-000076 | View SEC Doc Filr Page |
| 8-K | 2026-08-26 | 2026-08-25 | 8-K | 0001599298-26-000074 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001599298-26-000071 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | 8-K | 0001193125-26-314214 | View SEC Doc Filr Page |
| 424B5 | 2026-07-23 | — | 424B5 | 0001193125-26-314210 | View SEC Doc Filr Page |
| 10-Q | 2026-07-23 | 2026-06-30 | 10-Q | 0001599298-26-000068 | View SEC Doc Filr Page |
| 8-K | 2026-07-23 | 2026-07-23 | 8-K | 0001599298-26-000067 | View SEC Doc Filr Page |
| 8-K | 2026-07-22 | 2026-07-22 | 8-K | 0001599298-26-000058 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | 8-K | 0001599298-26-000054 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-12 | FORM 4 | 0001507650-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-12 | FORM 4 | 0001055919-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-06-11 | 2026-06-10 | 8-K | 0001599298-26-000052 | View SEC Doc Filr Page |
| 424B5 | 2026-06-10 | — | 424B5 | 0001193125-26-264471 | View SEC Doc Filr Page |
| S-3ASR | 2026-06-09 | — | S-3ASR | 0001193125-26-263861 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-04 | FORM 4 | 0001055919-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-04 | FORM 4 | 0001507650-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-06-04 | 2026-06-04 | FORM 4 | 0001569769-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-02 | 8-K | 0001599298-26-000049 | View SEC Doc Filr Page |
| 8-K | 2026-06-01 | 2026-05-30 | 8-K | 0001599298-26-000043 | View SEC Doc Filr Page |
| 10-Q | 2026-04-30 | 2026-03-31 | 10-Q | 0001599298-26-000039 | View SEC Doc Filr Page |